245 related articles for article (PubMed ID: 23323004)
21. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
[TBL] [Abstract][Full Text] [Related]
22. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.
Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S
Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580
[TBL] [Abstract][Full Text] [Related]
23. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
[TBL] [Abstract][Full Text] [Related]
24. [Predictive value of quantitative dynamic contrast-enhanced magnetic resonance imaging for the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer].
Zhu YJ; Li Y; Jiang J; Zhang W; Xue LY; Zhou AP; Jiang LM
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):765-770. PubMed ID: 31648499
[No Abstract] [Full Text] [Related]
25. Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer.
Monti M; Prochowski Iamurri A; Bianchini D; Gallio C; Esposito L; Montanari D; Ruscelli S; Molinari C; Foca F; Passardi A; Vittimberga G; Morgagni P; Frassineti GL
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630794
[TBL] [Abstract][Full Text] [Related]
26. Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.
Kim T; Kang DK; An YS; Yim H; Jung YS; Kim KS; Kang SY; Kim TH
Acta Radiol; 2014 May; 55(4):399-408. PubMed ID: 23963151
[TBL] [Abstract][Full Text] [Related]
27. [Accuracy comparision of abdominal enhanced CT and endoscopic ultrasound in the staging of gastric cancer after neoadjuvant chemotherapy: a post hoc analysis of a randomized clinical trial].
Wang YK; Shan F; Ying XJ; Zhang Y; Xiao QY; Tang L; Wu Q; Li ZY; Ji JF
Zhonghua Wai Ke Za Zhi; 2020 Aug; 58(8):614-618. PubMed ID: 32727193
[No Abstract] [Full Text] [Related]
28. Evaluation of the prognostic impact of pathologic response to preoperative chemotherapy using Mandard's Tumor Regression Grade (TRG) in gastric adenocarcinoma.
Derieux S; Svrcek M; Manela S; Lagorce-Pages C; Berger A; André T; Taieb J; Paye F; Voron T
Dig Liver Dis; 2020 Jan; 52(1):107-114. PubMed ID: 31427088
[TBL] [Abstract][Full Text] [Related]
29.
Schneider PM; Eshmuminov D; Rordorf T; Vetter D; Veit-Haibach P; Weber A; Bauerfeind P; Samaras P; Lehmann K
BMC Cancer; 2018 May; 18(1):548. PubMed ID: 29743108
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression.
Tang L; Li ZY; Li ZW; Zhang XP; Li YL; Li XT; Wang ZL; Ji JF; Sun YS
Clin Radiol; 2015 Nov; 70(11):1198-204. PubMed ID: 26188843
[TBL] [Abstract][Full Text] [Related]
31. Prediction of Treatment Outcome of Chemotherapy Using Perfusion Computed Tomography in Patients with Unresectable Advanced Gastric Cancer.
Lee DH; Kim SH; Lee SM; Han JK
Korean J Radiol; 2019 Apr; 20(4):589-598. PubMed ID: 30887741
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic ultrasound in restaging and predicting pathological response for advanced gastric cancer patients after neoadjuvant chemotherapy.
Guo T; Yao F; Yang AM; Li XY; Zhong DR; Wu DS; Wu X; Lu XH
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e28-32. PubMed ID: 23279745
[TBL] [Abstract][Full Text] [Related]
33. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST).
Jiang T; Kambadakone A; Kulkarni NM; Zhu AX; Sahani DV
Invest Radiol; 2012 Jan; 47(1):11-7. PubMed ID: 21512396
[TBL] [Abstract][Full Text] [Related]
34. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
35. Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Lorenzen S; Herrmann K; Weber WA; Wieder H; Hennig M; Ott K; Bredenkamp R; Peschel C; Schwaiger M; Lordick F
Nuklearmedizin; 2007; 46(6):263-70. PubMed ID: 18084682
[TBL] [Abstract][Full Text] [Related]
36. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
37. [Application of dual-channel contrast-enhanced ultrasound in classification of hilar cholangiocarcinoma and diagnosis of etiology of low biliary obstruction].
Wang LL; Nie F; Wang YQ; Tan YT; Zhu YY
Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1262-1268. PubMed ID: 34865396
[No Abstract] [Full Text] [Related]
38. Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer.
Hulikal N; Gajjala SR; Kalawat T; Kadiyala S; Kottu R
Asian Pac J Cancer Prev; 2020 Jan; 21(1):93-98. PubMed ID: 31983170
[TBL] [Abstract][Full Text] [Related]
39. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
[TBL] [Abstract][Full Text] [Related]
40. Application value of stomach filling ultrasonography and intravenous contrast agents in diagnosis of advanced gastric cancer.
Zhou SF; Yin JB; Yang H; Zhong J; An P
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3206-10. PubMed ID: 27466993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
